These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38502780)

  • 41. Structural Insights into the Unique Modes of Relaxin-Binding and Tethered-Agonist Mediated Activation of RXFP1 and RXFP2.
    Sethi A; Bruell S; Ryan T; Yan F; Tanipour MH; Mok YF; Draper-Joyce C; Khandokar Y; Metcalfe RD; Griffin MDW; Scott DJ; Hossain MA; Petrie EJ; Bathgate RAD; Gooley PR
    J Mol Biol; 2021 Oct; 433(21):167217. PubMed ID: 34454945
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of signaling pathways activated by the relaxin family peptide receptors, RXFP1 and RXFP2, using reporter genes.
    Halls ML; Bathgate RA; Summers RJ
    J Pharmacol Exp Ther; 2007 Jan; 320(1):281-90. PubMed ID: 17065365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The different ligand-binding modes of relaxin family peptide receptors RXFP1 and RXFP2.
    Scott DJ; Rosengren KJ; Bathgate RA
    Mol Endocrinol; 2012 Nov; 26(11):1896-906. PubMed ID: 22973049
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthetic covalently linked dimeric form of H2 relaxin retains native RXFP1 activity and has improved in vitro serum stability.
    Nair VB; Bathgate RA; Separovic F; Samuel CS; Hossain MA; Wade JD
    Biomed Res Int; 2015; 2015():731852. PubMed ID: 25685807
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of the novel bioluminescent ligand-receptor binding assay to relaxin-RXFP1 system for interaction studies.
    Wu QP; Zhang L; Shao XX; Wang JH; Gao Y; Xu ZG; Liu YL; Guo ZY
    Amino Acids; 2016 Apr; 48(4):1099-1107. PubMed ID: 26767372
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prolonged RXFP1 and RXFP2 signaling can be explained by poor internalization and a lack of beta-arrestin recruitment.
    Callander GE; Thomas WG; Bathgate RA
    Am J Physiol Cell Physiol; 2009 May; 296(5):C1058-66. PubMed ID: 19279230
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The complex binding mode of the peptide hormone H2 relaxin to its receptor RXFP1.
    Sethi A; Bruell S; Patil N; Hossain MA; Scott DJ; Petrie EJ; Bathgate RAD; Gooley PR
    Nat Commun; 2016 Apr; 7():11344. PubMed ID: 27088579
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of a selective agonist for relaxin family peptide receptor 3.
    Wei D; Hu MJ; Shao XX; Wang JH; Nie WH; Liu YL; Xu ZG; Guo ZY
    Sci Rep; 2017 Jun; 7(1):3230. PubMed ID: 28607363
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of Novel High-Affinity Antagonists for the Relaxin Family Peptide Receptor 1.
    Hossain MA; Praveen P; Noorzi NA; Wu H; Harrison IP; Handley T; Selemidis S; Samuel CS; Bathgate RAD
    ACS Pharmacol Transl Sci; 2023 May; 6(5):842-853. PubMed ID: 37200817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2.
    Mookerjee I; Hewitson TD; Halls ML; Summers RJ; Mathai ML; Bathgate RA; Tregear GW; Samuel CS
    FASEB J; 2009 Apr; 23(4):1219-29. PubMed ID: 19073841
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The relaxin receptor RXFP1 signals through a mechanism of autoinhibition.
    Erlandson SC; Rawson S; Osei-Owusu J; Brock KP; Liu X; Paulo JA; Mintseris J; Gygi SP; Marks DS; Cong X; Kruse AC
    Nat Chem Biol; 2023 Aug; 19(8):1013-1021. PubMed ID: 37081311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Indole-Containing Amidinohydrazones as Nonpeptide, Dual RXFP3/4 Agonists: Synthesis, Structure-Activity Relationship, and Molecular Modeling Studies.
    Guan D; Rahman MT; Gay EA; Vasukuttan V; Mathews KM; Decker AM; Williams AH; Zhan CG; Jin C
    J Med Chem; 2021 Dec; 64(24):17866-17886. PubMed ID: 34855388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8).
    Halls ML; Bond CP; Sudo S; Kumagai J; Ferraro T; Layfield S; Bathgate RA; Summers RJ
    J Pharmacol Exp Ther; 2005 May; 313(2):677-87. PubMed ID: 15649866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Progesterone withdrawal, and not increased circulating relaxin, mediates the decrease in myometrial relaxin receptor (RXFP1) expression in late gestation in rats.
    Vodstrcil LA; Shynlova O; Westcott K; Laker R; Simpson E; Wlodek ME; Parry LJ
    Biol Reprod; 2010 Nov; 83(5):825-32. PubMed ID: 20686183
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanisms.
    Halls ML; Bathgate RA; Summers RJ
    Mol Pharmacol; 2006 Jul; 70(1):214-26. PubMed ID: 16569707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.
    Halls ML; van der Westhuizen ET; Bathgate RA; Summers RJ
    Br J Pharmacol; 2007 Mar; 150(6):677-91. PubMed ID: 17293890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relaxin signaling activates peroxisome proliferator-activated receptor gamma.
    Singh S; Bennett RG
    Mol Cell Endocrinol; 2010 Feb; 315(1-2):239-45. PubMed ID: 19712722
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sex- and age-specific differences in relaxin family peptide receptor expression within the hippocampus and amygdala in rats.
    Meadows KL; Byrnes EM
    Neuroscience; 2015 Jan; 284():337-348. PubMed ID: 25313002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Further Developments towards a Minimal Potent Derivative of Human Relaxin-2.
    Handley TNG; Praveen P; Tailhades J; Wu H; Bathgate RAD; Hossain MA
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of RXFP1 Is Decreased in Idiopathic Pulmonary Fibrosis. Implications for Relaxin-based Therapies.
    Tan J; Tedrow JR; Dutta JA; Juan-Guardela B; Nouraie M; Chu Y; Trejo Bittar H; Ramani K; Biswas PS; Veraldi KL; Kaminski N; Zhang Y; Kass DJ
    Am J Respir Crit Care Med; 2016 Dec; 194(11):1392-1402. PubMed ID: 27310652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.